Predicting Premature Treatment Termination in Inpatient Psychotherapy: A Machine Learning Approach
1 other identifier
observational
2,023
0 countries
N/A
Brief Summary
The study aims to develop a prediction model of premature treatment termination in psychosomatic hospitals using a machine learning approach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2015
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
August 11, 2023
CompletedFirst Posted
Study publicly available on registry
September 18, 2023
CompletedSeptember 18, 2023
September 1, 2023
7 years
August 11, 2023
September 15, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Premature treatment termination (vs. treatment completion)
Premature treatment termination will be classified based on the treatment duration. Classification will be made retrospectively for each patient based on the duration of the inpatient treatment and if applicable (duration \< 49 days) on the hospital discharge letter to screen for reasons of the shorter treatment duration.
Premature treatment termination will be operationalized as a dummy variable. Regular treatment duration is 8 weeks of inpatient psychotherapy. Data will be reported for 7 years of continuous study enrolment (01/2015 - 01/2022).
Interventions
Patients treated at the inpatient psychotherapy unit of the University Hospital receive 8 to 10 weeks of multimodal psychotherapeutic treatment. Treatment consists of individual as well as group psychodynamic therapy. Additionally, patients receive an individual combination of music, art, relaxation and body-oriented group therapy. Therapeutic treatment is provided by a multiprofessional, interdisciplinary team of psychotherapists with either a medical or psychology degree, art and music therapists, specialist nurses, social workers, and physiotherapists.
Eligibility Criteria
The study population consists of patients being treated at the inpatient unit of University Hospital Heidelberg, department for psychosomatic medicine.
You may qualify if:
- patients of at least 18 years of age
- included in inpatient psychotherapy treatment program in a hospital for psychosomatic medicine
- provided information about admission and discharge date
You may not qualify if:
- bipolar, acute psychotic or substance abuse disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ulrike Dinger-Ehrenthal, Prof. Dr.
Department of Psychosomatic Medicine and Psychotherapy, Medical Faculty, Heinrich-Heine University Düsseldorf
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 11, 2023
First Posted
September 18, 2023
Study Start
January 1, 2015
Primary Completion
January 1, 2022
Study Completion
January 1, 2022
Last Updated
September 18, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because study data is provided by mental health patients and is therefore subject to strict protection.